
Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center. The study followed 16 patients, including Barbara Brigham, who joined the trial after a routine scan discovered her early-stage pancreatic cancer. Alongside surgery and chemotherapy, patients received a… read on > read on >